Local News Add Fatty Acid to Taste: New Technology Reveals Single Cancer Cells Have Different Appetites for Fatty AcidsInstitute for Systems Biology | July 20, 2021A new method developed by Institute for Systems Biology (ISB) and University of California, Riverside…kchenJuly 20, 2021 Read More
Local News Seattle-Based Shape Therapeutics Raises $112M to Develop RNA-Editing and Gene TherapiesGeekWire | July 20, 2021Shape Therapeutics, a Seattle preclinical stage biotech company developing RNA editing and gene therapy technologies,…kchenJuly 20, 2021 Read More
Local News Fred Hutchinson Cancer Research Center, Seattle Children’s and UW Medicine Lay Groundwork for Historic Cancer PartnershipFred Hutch | July 16, 2021Fred Hutchinson Cancer Research Center, UW Medicine, Seattle Cancer Care Alliance and Seattle Children’s today…kchenJuly 16, 2021 Read More
Local News FDA Approves Accelerated Dosing in Non-Hodgkin’s Lymphoma/Leukemia Clinical TrialAVM Biotechnology | July 16, 2021AVM Biotechnology, a clinical-stage company, announced today FDA permission to modify its ongoing clinical study,…kchenJuly 16, 2021 Read More
Local News Kineta Announces First Participant Dosed in Phase 1 Multiple Ascending Dose Clinical Trial of KCP506Kineta | July 15, 2021Kineta Inc, through its subsidiary Kineta Chronic Pain LLC, announced today that the first participant…kchenJuly 15, 2021 Read More
Local News Aurion Biotech Appoints Dr. Shigeru Kinoshita to Its Medical Advisory BoardAurion Biotech | July 15, 2021Shigeru Kinoshita, MD, PhD, has joined the medical advisory board at Aurion Biotech, whose mission is…kchenJuly 15, 2021 Read More
Local News Deleted SARS-CoV-2 Sequences from Early in Wuhan Outbreak Offer CluesFred Hutch | July 14, 2021In a report first published on the preprint server bioRxiv on June 22, Fred Hutchinson Cancer Research…kchenJuly 14, 2021 Read More
Local News US FDA Grants Regular Approval and Expands Indication for PADCEV®Seagen | July 13, 2021Seagen Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D.,…kchenJuly 13, 2021 Read More
Local News Seattle Children’s Pioneering Immunotherapy Trial May Be Feasible to Combat Pediatric Brain and Spinal Cord TumorsSeattle Children’s | July 13, 2021An innovative clinical trial led by Dr. Nicholas Vitanza, a neuro-oncologist at Seattle Children’s, shows…kchenJuly 13, 2021 Read More
Local News Silverback Therapeutics Announces Clinical Supply Agreement with Regeneron to Evaluate SBT6050 in Combination with LibtayoBusiness Wire | July 9, 2021Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”), a clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology…kchenJuly 9, 2021 Read More